Nautilus Biotechnology, Inc. Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease)
Nautilus Biotechnology, Inc. (NAUT) reported Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease) of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Credit Losses › Allowance for Credit Loss
us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease · last filed 2026-07-28
- Nautilus Biotechnology, Inc. debt securities, available-for-sale, allowance for credit loss, period increase (decrease) for the quarter ending 2026-06-30 was $0.00.
- Nautilus Biotechnology, Inc. debt securities, available-for-sale, allowance for credit loss, period increase (decrease) for the quarter ending 2026-03-31 was $0.00.
- Nautilus Biotechnology, Inc. debt securities, available-for-sale, allowance for credit loss, period increase (decrease) for the quarter ending 2025-12-31 was $0.00.
- Nautilus Biotechnology, Inc. debt securities, available-for-sale, allowance for credit loss, period increase (decrease) for the quarter ending 2025-09-30 was $0.00.
- Nautilus Biotechnology, Inc. debt securities, available-for-sale, allowance for credit loss, period increase (decrease) for fiscal 2025 was $0.00.
- Nautilus Biotechnology, Inc. debt securities, available-for-sale, allowance for credit loss, period increase (decrease) for fiscal 2024 was $0.00.
- Nautilus Biotechnology, Inc. debt securities, available-for-sale, allowance for credit loss, period increase (decrease) for fiscal 2023 was $0.00.
- Nautilus Biotechnology, Inc. debt securities, available-for-sale, allowance for credit loss, period increase (decrease) for fiscal 2022 was $0.00.
| Period end | Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease) 3 month | Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease) 6 month | Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease) 9 month | Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-28 | $0.00 10-Q · filed 2026-07-28 | $0.00 derived: sum of 3 quarters · filed 2026-07-28 | $0.00 derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | $0.00 10-Q · filed 2026-04-28 | $0.00 derived: sum of 2 quarters · filed 2026-04-28 | $0.00 derived: sum of 3 quarters · filed 2026-04-28 | $0.00 derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-07-28 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 10-Q · filed 2025-10-28 | $0.00 derived: sum of 2 quarters · filed 2026-07-28 | $0.00 10-Q · filed 2025-10-28 | $0.00 derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $0.00 10-Q · filed 2026-07-28 | $0.00 10-Q · filed 2026-07-28 | $0.00 derived: sum of 3 quarters · filed 2026-07-28 | $0.00 derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $0.00 10-Q · filed 2026-04-28 | $0.00 derived: sum of 2 quarters · filed 2026-04-28 | $0.00 derived: sum of 3 quarters · filed 2026-04-28 | $0.00 derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 10-Q · filed 2025-10-28 | $0.00 derived: sum of 2 quarters · filed 2025-10-28 | $0.00 10-Q · filed 2025-10-28 | $0.00 derived: sum of 4 quarters · filed 2025-10-28 |
| 2024-06-30 | $0.00 10-Q · filed 2025-07-31 | $0.00 10-Q · filed 2025-07-31 | $0.00 derived: sum of 3 quarters · filed 2025-07-31 | $0.00 derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $0.00 10-Q · filed 2025-04-29 | $0.00 derived: sum of 2 quarters · filed 2025-04-29 | $0.00 derived: sum of 3 quarters · filed 2025-04-29 | $0.00 derived: sum of 4 quarters · filed 2025-04-29 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-29 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | $0.00 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-07-30 | $0.00 10-Q · filed 2024-07-30 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-04-30 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |